342
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Should rotavirus vaccines be included in the national immunization program of a small developed country?

&
Pages 401-404 | Published online: 09 Jan 2014
 

Acknowledgements

The authors thank Stewart Reid and Paul Scuffham for helpful comments.

Financial & competing interests disclosure

Richard Milne has received funding from Merck and Co. for an economic evaluation of RotaTeq®. Keith Grimwood has been a member of a Rotavirus Advisory Board and received support for conference attendance, lecture fees and a research grant from GlaxoSmithKline; he has also received a research grant from Merck and Co. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.